Alterity’s ATH434 Gets FDA Fast Track for Multiple...
Category : ODD/BTA/FTA Status 6 May 2025Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...
Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...
OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announces that the US Food...
Baebies, a North Carolina-based diagnostics company, has received Breakthrough Device Designation fr...
The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products...
Avidity Biosciences, Inc, a biopharmaceutical company committed to delivering a new class of RNA the...